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Summary Previous studies showed that murine polymorphonuclear leukocytes (PMNs) lyze tumour cells in
the presence of wheat germ agglutinin or actinomycin D. This paper reports studies on whether a soluble
factor participates in PMN-mediated cytolysis dependent on lectin or a chemotherapeutic drug. Tumour lysis
was observed with supernatants from PMN cocultured with wheat germ agglutinin or actinomycin D. The
supernatant from cultures of PMNs alone was not cytotoxic, but addition of these agents to the supernatant
induced tumour lysis. PMNs released a soluble factor spontaneously into the medium and cytolysis was
induced by a combination of this factor and wheat germ agglutinin or actinomycin D. This factor was not an
oxygen metabolite, but a protein with a molecular weight of - 100K daltons. These results suggest that a
soluble factor(s) from PMNs participates in tumour killing in cooperation with appropriate reagents.
Polymorphonuclear leukocytes (PMNs) are im-
portant in defence against infection and are also
found in histological sections of neoplasms and in
cytological preparations of malignant tissues
(Dvorak et al., 1978; Godleski et al., 1970; Slauson
et al., 1975). PMNs are cytotoxic in vitro to tumour
cells of animals (Fisher et al., 1979; Pickaver et al.,
1972; Lichtenstein & Kahle, 1985) and humans
(Chee et al., 1978; Gerrard et al., 1981; Korec et
al., 1980; Takasugi et al., 1975; Clark & Klebanoff,
1979).
Previously, we showed that PMNs from the
peritoneal cavity of mice could kill murine tumour
cells in vitro on addition of appropriate mediators;
viz plant lectins (Ikenami & Yamazaki, 1983),
animal lectins (Yamazaki et al., 1983) antitumour
antibody (Tsunawaki et al., 1983), anticancer
chemotherapeutic drugs (Ikenami et al., 1985) and
immunomodulators (Morikawa et al., 1985).
Reactive oxygen species produced by PMNs are
important in the lytic process by immuno-
modulators (Morikawa et al., 1985), but the
mechanisms of other types of killing are unknown.
In this work, we investigated the mechanisms of
PMN-mediated cytolysis dependent on lectin and
chemotherapeutic drug, by studies on whether
soluble factor from PMNs participates in tumour
killing in vitro. We found that a PMN-derived
factor can lyse tumour cells in cooperation with
wheat germ agglutinin or actinomycin D and that
this factor is a protein of high molecular weight.
Materials and methods
Mice
Inbred male C3H/He and DDY mice were obtained
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from Shizuoka Experimental Animal Farm
(Shizuoka, Japan). Mice were used at 8-11 weeks
of age.
Tumour cells
MM46, a transplatable ascites tumour from a
spontaneous mammary adenocarcinoma in a
C3H/He mouse, was mainly used as a target cell.
MM48 mammary adenocarcinoma and MH134
hepatoma cells were also used as target cells. L929
cells were harvested from in vitro culture.
Polymorphonuclear leukocytes (PMNs)
Cells were prepared as described previously
(Tsunawaki et al., 1983). Briefly, 2ml of 12%
casein solution was injected into the peritoneal
cavity of mice and the peritoneal exudate was
harvested 6h later, passed through nylon mesh and
centrifuged at 300g for 5min. The precipitated cells
were washed twice with RPMI-1640 medium
(Nissui Seiyaku Co., Tokyo) supplemented with
10OUml-m of penicillin (Banyu Pharmaceutical
Co., Tokyo) and 100gml-l of streptomycin (Meiji
Seika Co., Tokyo). Usually, the peritoneal cells were
suspended in RPMI-1640 medium containing 5%
heat-inactivated foetal calf serum (Gibco, Grand
Island, NY; called medium hereafter). They were
stained with Giemsa stain and the proportions of
PMNs were determined by morphological
observation. These peritoneal cells, containing 93-
98% of polymorphonuclear leukocytes, were used as
the polymorphonuclear leukocyte preparation.
About 108 PMNs were obtained from a C3H/He
mouse.
Cytolytic assay
Cytolysis of MM46 tumour cells was assayed as
described previously (Yamazaki et al., 1975). Briefly,
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PMN-culture supernatants and 5 Cr-labelled
MM46 tumour cells (5 x 103 cells) were mixed in
wells (7mm diameter) of flat-bottomed microplates.
The mixture were incubated in 0.2ml of medium for
18-24h at 37°C under 5% CO2 in air and the
radioactivity of the supernatant was measured.
Cytolytic activity was calculated as follows:
Cytolysis (%) =
Experimental count-control count
Maximum releasable count-control count
Maximum release of 51Cr was measured by
freezing-thawing labelled tumour cells 3 times. The
control count was measured as the radioactivity
released from labelled cells in the presence of wheat
germ agglutinin or actinomycin D without culture
supernatant. The control count was usually equiva-
lent to the count released spontaneously from
labelled cells alone.
Cytolysis of L929 cells was measured by the
method of Ruff & Gifford (1980). Briefly, L929
cells (8 x 104 cells) and PMN-culture supernatants
were mixed in the wells (7mm diameter) of flat-
bottomed microplates, and incubated in a CO2
incubator for 18h. Then, the medium was removed
and residual cells were stained for 15min with
crystal violet. After addition of 0.1 ml of sodium
dodecyl sulfate (0.5%), absorbance at 590nm of the
supernatant was measured in a photometer
(Myreader 7, Sanko Junyaku Co., Ltd., Tokyo).
Cytolytic activity was calculated as follows:
Cytolysis (%) =
1 Experimental absorbance 0
Control absorbance
Cytolysis in Marbrook vessels
Marbrook vessels with 2 chambers separated by a
nuclepore membrane (Pore size, 0.4pm; thickness
lOpm; Nuclepore Co., Pleasanton, CA) were
prepared. PMNs (1.2 x 107) were introduced into
the outer chamber, and 3 x 104 51Cr-labelled MM46
tumour cells were into the inner chamber. The cells
were incubated in 2ml of medium with or without
wheat germ agglutinin (30pgml-') at 370C for
24h. As controls, 5'Cr-labelled MM46 tumour cells
were placed in the outer chamber with PMNs.
After incubation, the radioactivities of the
supernatants of the inner and outer chambers were
measured.
Reagents
Wheat germ agglutinin was purchased from E-Y
Laboratories (San Mateo, CA). Actinomycin D,
catalase, arginine, trypsin and soybean trypsin
inhibitor were obtained from Sigma Chemical Co.,
(St. Louis, MO). Leupeptin and bestatin were gifts
from Dr T. Takeuchi (Institute of Microbiol
Chemistry, Tokyo).
Gelfiltration
The PMN-culture supernatant was applied to a
column of Sephacryl S-300 (Pharmacia Fine
Chemicals, Sweden) previously equilibrated with
phosphate-buffered saline (pH7.4) and material was
eluted with the same buffer. Fractions of 10ml were
collected and their cytolytic activity was tested in
the presence of wheat germ agglutinin or
actinomycin D.
Results
Cytolytic activity ofsupernatants ofcultures of
PMNs
We used Marbrook vessels to study the role cell-to-
cell interaction in cytolysis, i.e. whether effector-
target cell interaction is necessary for cytolysis.
When effector PMNs and target tumour cells were
incubated separately in different chambers, cytolysis
was observed in the presence of wheat germ
agglutinin just as when both types of cells were
incubated in the same chamber (Figure 1). When
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Figure 1 Wheat germ agglutinin-dependent PMN-
mediated tumour lysis in Marbrook vessels. *MM46;
5'Cr labelled MM46 tumour cells, MM46: intact
MM46 tumour cells. WGA: wheat germ agglutinin.
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unlabelled tumour cells were killed by PMNs in th
outer chamber in the presence of wheat gern
agglutinin, 51Cr-labelled tumour cells in the inne
chamber were also killed.
Similar results were obtained in actinomycin
dependent PMN-mediated cytolysis: cell-fre
supernatants from cocultures of PMNs wit]
actinomycin D lysed tumour cells (Figure 2).
These results suggested that direct contac
between effector PMNs and target tumour cells wa
not essential for tumour lysis and that the lysi
involved a soluble factor(s) released into th
medium.
Culture medium
from
PMN alone
PMN + Act.D
Cytolysis (%)
20 0
Tumor alone]
Tumor + Act. D
Figure 2 Cytolytic activity of culture medium. PMNs
(1 x 107 cells) or MM46 tumour cells (3 x 105 cells)
were cultured for 1 h with or without actinomycin D
(5ygml-1). Medium containing 50% culture super-
natant and 51Cr labelled MM46 tumour cells (5 x 103
cells) was incubated for 18h. Bar indicates sd (n =3).
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Figure 3 shows the dose-response curves of
culture supernatants from PMNs with wheat germ
agglutinin and actinomycin D respectively.
Cytolytic activities were detected with up to 4-fold
dilutions of both supernatants.
Characterization ofsupernatantsfrom cultures of
PMNs
Is The specificity of cytolysis was examined with
Is several kinds of target cells. Table I shows that 3
e other syngeneic tumour cells, MM48, MH134 and
L929 cells, were lyzed by the supernatant of
cultures of PMNs with wheat germ agglutinin.
However, no cytolysis of normal spleen cells was
observed.
Next, we examined whether proteases, arginase
and oxygen metabolites act as lytic substances in
cytolysis by the supernatants. For examination of
the effects of proteases the following inhibitors were
used: soybean trypsin inhibitor against trypsin,
leupeptin against plasmin, trypsin and papain, and
bestatin against aminopeptidase B and leucine
aminopeptidase. For examination of the effects of
oxygen metabolities, such as H202, catalase was
used as a scavenger of these substances. As shown
in Table II, protease inhibitors, oxygen scavenger
and arginine did not inhibit the cytolytic activities
of either supernatant.
Next, we examined the effects of heat- and
trypsin-treatments on the cytolytic activities of
a b
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Figure 3 Cytolytic activity of supernatants from PMN-coculture with lectin or actinomycin D. (a) PMNs
(2 x 107 cells) were cultures with (A) or without (A) actinomycin D (0.5 jigml-1) for 3h. Medium containing
the indicated concentration of culture supernatant and L929 cells (8 x 104 cells) was incubated for 18 h. (b)
PMNs (2 x107 cells) were cultured with (0) or without (0) wheat germ agglutinin (100Mgml-') for 3 h.
Medium containing the indicated concentration of culture supernatant and L929 cells (8 x 104 cells) was
incubated for 18h. Bars indicate sd (n = 3).
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Table I Target specificity of supernatants from PMN cultures
Cytolysis (%) oftarget cellsb
Supernatantbfrom MM46 MM48 MH134 L929 Spleen cells
PMN culture 0+1 0+1 10+5 13+2 -1
PMN coculture
with wheat
germ agglutinin 56+11 42+4 27+9 60+7 -3
'Supematants were obtained after 5h cultures of PMNs with or without
wheat germ agglutinin (50gml-1); bCytolysis of tumour cells was assayed by
51Cr release method. Cytolysis of spleen cells was determined by the dye
exclusion test. Cytolysis (35%) by medium alone was subtracted as a
background value. Mean+s.d. (n=3).
Table II Effects of various treatments on cytolytic activities ofculture supernatants
Cytolysis (%) by supernatantb with
actinomycin D wheat germ agglutinin
before after before after
Treatment' treatment treatment treatment treatment
Protease inhibitor
soybean trypsin inhibitor ( mgml1) 21+5 21 +3 19+3 19+3
leupeptin (125igml-') N.D. 17+1 22+5
bestatin (125ugml-1) N.D. 17+1 16+2
Catalase (1000Uml-1) 26+7 23+2 ND
(2000Uml-') N.D. 17+3 16+2
Arginie(500gigml-') 31+2 25+6 19+3 16+2
Trypsin (250pgml-1) 19+2 2+1* 11+1 4+1*
(500 gmml) 19+2 0+4* ND
Heating (560, 30') 21+2 5+3* 17+1 13+2*
(70°, 60') 21+2 0+1* 17+1 0+3*
'Various inhibitors were added to the culture supernatant before its cytolytic activity
was assayed; bSupernatants were obtained after 5 h-cocultures of PMNs with actinomycin
D (0.5pgmln l) or wheat germ agglutinin (100 gml-1); *=significant difference
(P<0.05).
supernatants. Table II shows that the cytolytic
activity was lost on heating at 700 for 1 h and on
trypsin treatment.
Spontaneous release ofthe solublefactorfrom
PMNs
As described above, supernatants from PMNs
cocultured with wheat germ agglutinin or
actinomycin D were cytolytic, but supernatants
from PMNs cultured alone were not. Next, we
examined whether these reagents were required to
induce a factor from PMNs i.e., whether addition
of these reagents to supernatants from PMNs
cultured alone induced tumour lysis as well as
supernatants from PMNs cocultured with these
reagents.
As shown in Table III, tumour lysis was induced
by addition of wheat germ agglutinin or
actinomycin D to supernatants of PMN cultures.
The supernatant alone was not cytolytic to tumour
cells. Thus, cytolysis seemed to be induced by
combination of a factor from PMNs and these
reagents, and PMNs seemed to release this factor
spontaneously into the medium.
The kinetics of release of this factor is shown in
Figure 4. Maximum release was observed within
5h, and no cytolytic activity was detected in super-
natants of overnight cultures. Therefore, this factor
may be released spontaneously from fresh PMNs
but not from damaged or dead PMNs.
Next, the nature of the factor that induced
cytolysis in cooperation with wheat germ agglutinin
or actinomycin D was examined by subjecting theNEUTROPHIL-DERIVED FACTOR IN TUMOUR LYSIS
Table III Cytolytic activities of supernatants from PMN-
cultures
Addition of Cytolysisc
Culturea drug in assayb (%)
PMNs+actinomycin D None 17+4
PMNs alone Actinomycin D 22+1
PMNs alone None 3+3
PMNs+wheat
germ agglutinin None 22+4
PMNs alone Wheat germ
agglutinin 20+6
PMNs alone None 0+5
aSupernatants were obtained from cultures of PMNs
with or without drugs for 5h; bActinomycin D (1 pgml-1)
or wheat germ agglutinin (50igml-1) was added to the
supernantant of PMNs cultured alone and then cytolysis
was assayed; 'Cytolysis of MM46 tumour cells was
assayed. Mean+sd (n=3).
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Figure 4 Time course of spontaneous release of
PMN-factor. PMNs (2 x 10' cells) were cultured alone
in PBS (lml) and supernatants were obtained at the
indicated times. Medium containing 50% of PMN-
culture supernatant and 5"Cr-labelled MM46 tumour
cells (5 x 103 cells) was incubated for 24h with
actinomycin D (0.3ygml-1) (A), or wheat germ
agglutinin (50 yg ml- ) (0). Bars indicate sd (n= 3).
supernatants from serum free-cultures of PMNs to
gel filtration on Sephacryl S-300. As shown in
Figure 5, the cytolytic activity was recovered in a
fraction corresponding to a mol. wt of about
- 100K daltons.
Discussion
Previously we observed mediator-dependent
cytolysis when murine syngeneic tumour cells were
lyzed by casein-induced peritoneal PMNs in the
Fraction number (10 ml/fr.)
Figure 5 Gel filtration of PMN-culture supernatants.
PMNs (2 x 107 cellsml-1) were cultured for 5h in
23ml PBS. Concentrated supernatants (3ml) were
applied to a Sephacryl S-300 column (1.8 x 100cm) and
fraction of 10ml were collected. Medium containing
50% of eluant and L929 cells (8 x 104 cells) were
incubated for 18h in the presence of actinomycin D
(0.25ugml-') (A), or wheat germ agglutinin
(25pgml-') (0). (0) Absorbance at 280nm. Marker
proteins such as ferritin (440K daltons), aldolase (158 K
daltons) and ovalbumin (43 K daltons) were previously
chromatographed on the same column.
presence of lectins (Ikenami & Yamazaki, 1983:
Tsunawaki et al., 1983; Yamazaki et al., 1983),
anti-cancer chemotherapeutic drugs (Ikenami et al.,
1985) or immunomodulators (Morikawa et al.,
1985a). In the present work, we examined the
mec4anisms of lectin- drugs-dependent PMN-
mediated cytolysis. We found that supernatants
from PMNs cocultured with wheat germ agglutinin
or actinomycin D could lyse tumour cells (Figure 1
and 2). As far as we know, tumour lysis by the
supernatant of PMN cultures has not been reported
previously. We also observed tumour lysis on
addition of wheat germ agglutinin or actinomycin
D to the supernatant of PMNs cultured alone
(Table III). However, the factor itself was not
cytolytic to tumour cells. Thus, cytolysis seemed to
be induced by the action of the factor with these
reagents.
In our system, contamination with macrophages
was slight (<3%) and purified PMNs (99.1-99.5%)
also showed cytolytic activity in the presence of
actinomycin D (Ikenami et al., 1985) and wheat
germ agglutinin (Tsunawaki et al., 1983).
Moreover, this factor was released spontaneously
from glass-nonadherent cells, but not from glass-
adheremt macrophage-rich cells, and PMNs could
not lyse tumour cells in the presence of lipopoly-
saccharide, which is known to activate macrophages
(data not shown). Therefore, the PMN-mediated
cytolysis was not due to contaminating
macrophages.
579580 M. IKENAMI & M. YAMAZAKI
Most previous studies on PMN cytotoxicity have
focussed on oxygen metabolities. PMNs have been
shown to kill tumour cells through oxygen-
dependent pathways (Clark & Klebanoff, 1979:
Nathan et al., 1979; Dallegri et al., 1983). We also
reported that hydrogen peroxide was an effector
molecule in immunomodulator-dependent PMN-
mediated tumour lysis (Morikawa et al., 1985b).
However, the present factor was different from
oxygen metabolites such as hydrogen peroxide
(Table II). This factor seemed to have a mol. wt of
about -100K daltons (Figure 5), and to be a
protein, since it was heat-labile and inactivated by
trypsin (Table II). The activity was not inhibited by
protease inhibitors and arginine. These data suggest
that the factor is neither protease nor arginase,
which are known to be effector molecules of
macrophages. A lysosomal cationic protein from
PMNs that induces cytolysis has been reported
(Thorne et al., 1984), but this seemed to differ from
our factor in mol. wt and its direct cytotoxicity on
target cells.
This factor was released spontaneously from
fresh PMNs (Figure 4). From this finding and the
fact that PMN-mediated cytolysis was inhibited by
an inhibitor of protein synthesis, cycloheximide
(data not shown), we conclude that damaged or
dead PMNs do not release the factor, but rather
that PMNs may die after production of this factor.
Spontaneous productions of cytotoxins by alveolar
macrophages (Sone et al., 1984) and a
macrophage-like cell line (Kull & Cuatrecases,
1984) have been reported. Our results suggest that
this may also be the case with PMNs: exudate
PMNs may secret a factor that participates in
target killing at an inflammatory site in vivo. In
fact, recently we found a similar soluble factor to
that reported here in inflammatory ascites
containing many PMNs (manuscript in
preparation). At present the primary action of this
factor on target cells and its synergistic actions with
wheat germ agglutinin and actinomycin D are not
clear. We are now purifying and characterizing the
factor further.
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